Chimeric Antigen Receptor-T (CAR-T) Cell Therapy Targeting BCMA in Patients with Prior Allogeneic Transplantation (allo-HCT) in Relapsed and/or Refractory Multiple Myeloma (RRMM)

Authors :: Lindsay Hammons
Shabi Haider
Marcelo C Pasquini
Saurabh Chhabra
Sabarinath Radhakrishnan
Anthony E. Zamora
Meera Mohan
Jing Dong
Siegfried Janz
Anita D'Souza
Parameswaran Hari
Binod Dhakal
Source :: Blood. 140:7215-7216
Publication Year :: 2022
Publisher :: American Society of Hematology, 2022.

Tools